ArticleThe Journal of biological chemistry2011

An "exacerbate-reverse" strategy in yeast identifies histone deacetylase inhibition as a correction for cholesterol and sphingolipid transport defects in human Niemann-Pick type C disease.

Andrew B Munkacsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.